Background
The treatment of AF has traditionally been pharmacological aimed at rate or rhythm control. However, rhythm control remains difficult to establish. Pulmonary vein isolation is reported to be effective in selected patient groups.
Methods
Ninety-nine consecutive patients with a mean age of 54±10 years who had paroxysmal or persistent AF were treated in the University Medical Centre of Groningen. All patients underwent PVI by the same electrophysiologist. Successful PVI was defined as absence of AF on Holter or electrocardiogram (ECG), and no complaints of AF.
Results
After 6 months of follow-up 60 (61%) patients did not have any AF episode, neither on 96-Holter monitoring nor on ECGs, and had no complaints related to AF. 39 of these 60 patients (65%) were no longer treated with any class I or III AAD. Independent determinants of successful PVI were paroxysmal AF (OR 18 [3.5-93] , P=0.001), and left atrial ablation time > 55 minutes (OR 15 [2.7-81] , P=0.002). Left atrial (parasternal view, 42±6 vs. 40±5 mm, P<0.05 and apical view, 61±9 vs. 58±8 mm, P<0.05), and right atrial sizes (59±7 vs. 56±5 mm, P<0.05) decreased significantly in the successfully treated patients after 6 months of follow up.
Conclusion
Independent determinants of a successful outcome after PVI are paroxysmal AF and a longer left atrial ablation time.
Introduction
Although large randomized controlled trials have shown that rate-control therapy is not inferior to rhythm-control therapy, rhythm control is indicated in specific patient populations 1, 2 . One of the main reasons for adopting rhythm control are symptoms caused by AF, and subsequently a low quality of life 3 . However, pharmacological rhythm-control therapy is only effective in maintaining sinus rhythm in 40% of all patients 4 . Adverse effects of AADs are another important disadvantage 5 . Nowadays, left atrial catheter ablation is widely used to prevent recurrences of AF. Pulmonary vein isolation alone may exert its beneficial effects by eliminating triggers of AF, autonomic denervation of the left atrium, and eliminating part of the arrhythmogenic substrate. Additional linear ablation lines e.g. at the left atrial roof and mitral isthmus may abolish more substrate. Pulmonary vein isolation is reported to be effective in 60-85% of the patients, especially in patients with paroxysmal short lasting episodes of AF [6] [7] [8] [9] . In about one third of the patients a second ablation procedure is necessary. The results reported in the journals are those achieved in high volume centres in France, the USA, Italy and Germany performing different types of ablation procedures, with or without additional ablation lines.
The purpose of this prospective observational study was (1) to describe the success of pulmonary vein isolation in a single operator referral centre in the Netherlands, (2) to determine predictors of success, (3) to determine beneficial changes of atrial sizes and ventricular function, and (4) to assess peri-procedural complications.
Methods

Patient population
The present patient population consists of 99 consecutive patients with AF. All patients underwent pulmonary vein isolation at the University Medical Centre Groningen, Groningen, The Netherlands, in the period between March 2003 and June 2007. Patients were eligible for pulmonary vein isolation if they met the following criteria: severely symptomatic paroxysmal or persistent AF despite the use of at least 2 AADs, or severe adverse events on rhythm-control drugs. Exclusion criteria were significant underlying heart diseases and age < 18 years or > 75 years. Hypertensive patients were not excluded if the blood pressure was under control.
Study design and follow-up
Patients were admitted to the hospital 1-2 days before the ablation. Oral anticoagulation was discontinued 2 days before the procedure and replaced by full dose low molecular weight heparin. At admission, a transesophageal echocardiography to exclude thrombi or spontaneous contrast in the atria, and an electronic beam tomography (EBT) or computed tomography (CT) to depict the left atrium and the pulmonary veins were performed. The EBT or CT scan was used during the procedure. Ablation was performed either during AF or sinus rhythm. Post-ablation heart rhythm was monitored with 48-hour telemetry and 48-hour Holter registration. Antiarrhythmic drugs were continued for at least 2 months. No electrical cardioversions were performed directly post-pulmonary vein isolation. Oral anticoagulation was restarted post-pulmonary vein isolation. Low molecular weight heparin was discontinued when the International Normalized Ratio (INR) >2.5 was achieved. Complications, i.e. haematoma, fistula, pericardial effusion, cardiac tamponade, pulmonary vein stenosis and thromboembolic complications were carefully monitored. When no complications occurred, the patient was discharged from hospital after two days. At 2 and 6 months after discharge the patients were seen at the outpatient department. At each visit, any cardiovascular events were recorded, and a 12-lead ECG, transthoracic echocardiography, 48-hours (at 6 month visit a 96-hours) Holter registration was obtained. At the 6 month visit an EBT, or CT scan was performed to assess pulmonary vein stenosis. When sinus rhythm was maintained > 2 months, the dose of AADs was lowered and eventually discontinued. Oral anticoagulant therapy was continued for at least 6 months.
Procedure of pulmonary vein isolation
All patients underwent circumferential PVI as described by Pappone 10 by the same electrophysiologist. Catheters were introduced percutaneously in the right femoral artery and vein using the Seldinger technique. One decapolar catheter (Cordis-Webster, Miami, FL, USA) with 5-mm electrodes and 2-mm interelectrode spacing was placed in the coronary sinus. Using a long introducer sheath (Bard Channel, Lowell, MA, USA) and a transseptal needle (Bard, Lowell, MA, USA), one transseptal puncture was made, through which the ablation catheter was advanced to the left atrium. A bolus of unfractionated heparin was administered after the first transseptal puncture and subsequent an additional bolus of heparin after 2 hours. Coronary sinus stimulation was performed with cycle lengths of 700 ms during ablation, both in sinus rhythm and in AF. The left atrium was mapped and the pulmonary veins were reconstructed using CARTO ® (Biosense-Webster, Diamond Bar, CA, USA). Then the CARTO ® left atrium map was aligned to the EBT or CT scan reconstruction of the left atrium.
All electrocardiograms were filtered at 30 to 250 Hz and displayed on an electrophysiologic recording system (Bard Electrophysiology). The ablation catheter was a curve D or F, irrigation tip (Biosense-Webster, Diamond Bar, CA, USA). Radiofrequency-energy delivery settings were limited at power ≤50 W and temperature ≤48 ºC. Lesions were delivered for a maximum of 40 s, or 25 s at the posterior wall of the left atrium. The left pulmonary veins were then isolated, starting with the isthmus between left atrial appendage and the upper left pulmonary vein and continuing for both left pulmonary veins and subsequently both right pulmonary veins. Pacing and mapping in all four pulmonary veins was repeated at the end of the procedure. Isolation was confirmed by mapping in the isolated areas for atrial spikes less than 0.6 mV and loss of pacing capture, with output in isolated areas of 20 mV duration 2 ms.
Endpoints
Primary endpoint was success of PVI after 6 months of follow-up. Success was defined as absence of AF, i.e. no evidence of AF, atrial flutter, or supraventricular arrhythmias on Holter monitoring or electrocardiogram > 30 seconds, and no complaints of AF. Secondary endpoints were changes in echocardiographic parameters and procedural complications (e.g. pulmonary vein stenosis, pericardial effusion, tamponade, transient ischemic attack, stroke, bleeding, esophagus perforation). Two independent observers adjudicated success of PVI.
Statistical analysis
Descriptive statistics are presented as the mean ± standard deviation (SD) or median (range) for continuous variables and counts with percentages for categorical variables. In case of normally distributed variables the Student t test and otherwise the Mann-Whitney U test was used. Paired t tests were used for comparison of the study population at different follow up times. Multivariate stepwise logistic regression analyses were performed to determine predictors of maintenance of sinus rhythm during follow-up. Continuous variables were categorized on the median value. All univariate predictors with P<0.1 were tested in a multivariate model. In the multivariate model a variable was excluded when P ≥ 0.05. Firstline interactions were investigated. All P-values were two-sided, and a P-value <0.05 was considered as statistically significant. Data analyses were performed using the program Statistical Package for the Social Sciences 16.0 (SPSS 16.0).
Results
Patient characteristics
A total of 99 patients who underwent PVI were included (table 1). Mean age was 54±10 years and 81% was male. Hypertension was present in the majority of patients. Median history of AF was long (7.0 [1.0-36.4] years).
Outcome
A total of 146 procedures were performed in 99 patients. 35 patients underwent one reablation, 6 patients underwent two re-ablations. The mean procedure time was 188 (100-294) minutes and the median radiation dose administered was 4,549 (943-15,743) cGycm2 (table 2). In 5 of the 41 re-ablations also a cavotricuspid ablation was performed for a typical atrial flutter. In the successfully treated patients ablation time of the left pulmonary veins and total procedure time was longer, and complete conduction block after ablation was significantly more often present (table 2) .
After 6 months of follow-up 60 (61%) patients did not have any AF episode, neither on 96-Holter monitoring nor on ECGs, and had no complaints related to AF. 39 of these 60 patients (65%) were no longer treated with any class I or III AAD. Figure 1 shows that the success of the procedure fluctuates between 60-70%. Figure 1 . Figure 1 . Figure 1 . Figure 1 . 
Independent determinants
Univariate analyses revealed that paroxysmal AF, left atrium ablation time, cardiomyopathy, and palpitations had a relation with a successful outcome (P<0.1). The multivariate regression analyses revealed that paroxysmal AF, and longer left atrial ablation time were independent predictors for a successful ablation for the total group (table 3) .
Follow-up
Left ventricular function was normal at baseline and did not change during follow up (table 4). Significant decreases of atrial sizes were observed in the successfully treated patients (table 4) . Holter monitoring revealed absence of AF after 6 months of follow up in the success group (table 5) .
Complications
Complications occurred in 2 of the 146 procedures (1.3%). In one patient pericardial effusion was complicated by a heart tamponade, which recovered after drainage. One patient had a stroke 2 weeks after the procedure. Four times a suspicion arose for pericardial effusion but on follow up echocardiogram no effusion was found. 
Discussion
The study shows that in a moderate volume referral centre PVI can be effectively and safely performed. PVI alone is more effective in selected patients with paroxysmal instead of persistent AF. Furthermore, a longer left atrial ablation time was associated with a higher success rate. 
Success of ablation
Success of PVI in our study was determined by type of AF and time of ablation. Paroxysmal AF and a shorter duration of AF are well known parameters related to success of this strategy [6] [7] [8] [9] . In addition, we observed that a longer left atrial ablation time determined outcome. This may be explained by several factors. First, a longer ablation time may increase the induction of continuous and transmural lesions required for success of the procedure. Comparably, Beukema et al. observed that patients with a successful outcome of PVI at long-term followup had higher troponin T plasma levels, whereas patients who remained in AF at long-term follow-up had significantly lower troponin plasma levels 11 . Second, it may relate to difficulties to transmurally ablate the left lateral ridge between the orifices of the left pulmonary veins and the left atrial appendage, which is often challenging 12 . Only after long and extensive ablation, transmural lesions may be achieved at that location, explaining the beneficial effects of longer left atrial ablation times.
We report a success percentage of 60%. This is slightly lower than what is reported in the literature. A learning curve of the operator can explain this but also the fact that almost half of our patients had persistent AF. Success of PVI alone for ablation of persistent AF is lower compared to success rates observed in paroxysmal AF patients. Success rates of 21% and 45% in patients with persistent AF treated with PVI alone have been reported [13] [14] [15] . Additional ablation lines and/ or ablating complex potentials in addition to PVI increases critically the success rate in these patients 15 . This emphasizes that type of AF is important in selecting patients for non-pharmacological rhythm control therapy.
Atrial sizes post-pulmonary vein isolation
In accordance with prior ablation studies atrial sizes significantly decreased in the successfully treated patients 11, 16 . Previous studies in patients who underwent serial electrical cardioversions T T T T and AAD institution also showed that maintenance of sinus rhythm reverted atrial enlargement 17 . This is an essential finding as left atrial size is a powerful predictor of adverse events including mortality in patients with cardiovascular diseases 18, 19 . None of the rate versus rhythm control trials so far showed beneficial effect of rhythm control with regard to cardiovascular morbidity and mortality. All these studies, however, were hampered by low rates of long term maintenance of sinus rhythm 1, 2, 20 . Possibly, the recently started ablation versus drug therapy for AF study (Cabana, ClinicalTrials.gov number NCT 00578617) may alter this consensus.
Role of atrial ablation for prevention of atrial fibrillation
Our report shows the efficacy of the present therapeutic strategy in paroxysmal AF patients. There are more data on single-center experiences, reporting similar findings about success and feasibility 21 . The Heart Rhythm Society (HRS)/ European Heart Rhythm Association (EHRA)/ European Cardiac Arrhythmia Society (ECAS) expert consensus statement on catheter and surgical ablation of AF states that when a patient fails on at least 1 AAD there is an indication for PVI 22 . This implies that PVI will become therapy of choice in a larger group of patients and will result in more pulmonary vein ablations in the near future.
In the Netherlands, long waiting lists hamper early treatment of AF patients eligible for this therapeutic strategy. The long waiting list in part relates to the few electrophysiologists experienced in performing these procedures. Certainly, improvement of techniques and training will reduce procedure times and increase the number of patients that can be treated. Nevertheless, it may be worthwhile to select patients who may benefit most from the ablation procedure. At present, patients with paroxysmal AF, a shorter duration of AF and without a significant left atrial size enlargement seem to be the best candidates for PVI 15, 22, 23 .
Limitations
In comparison with our colleagues in the USA, France, Germany and Italy, the population studied was smaller, 99 patients, and the time of ablation longer, reflecting less experience in performing pulmonary vein isolation. Furthermore, half of the patient population suffered from persistent AF. Pulmonary vein isolation alone seems less effective for these patients.
Conclusions
